Ozempic, Wegovy covered by Medicare and Medicaid under Biden admin proposal for anti-obesity GLP-1 drugs
Fox News
The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have Medicare and Medicaid.
Greg Norman is a reporter at Fox News Digital.
The new HHS proposal, they said, would require both Medicare and Medicaid to cover the drugs for people with obesity as a treatment for the condition.
"Today’s new proposal would expand access to these innovative medications for obesity, which is widely recognized as a disease and help an estimated 3.4 million Americans with Medicare. Medicare coverage would reduce out-of-pocket costs for these prescription drugs by as much as 95 percent for some enrollees," the White House said in a statement Tuesday.
Trump, Congress looking to put suffocating sanctions on 'kangaroo' ICC over Netanyahu arrest warrant
After the ICC’s legal assault on the Mideast’s only democracy, Israel, for its war on Hamas terrorism, a powerful U.S. legislative and executive campaign has emerged against the controversial body.